1. Home
  2. SPRC vs ENVB Comparison

SPRC vs ENVB Comparison

Compare SPRC & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • ENVB
  • Stock Information
  • Founded
  • SPRC 2004
  • ENVB 1994
  • Country
  • SPRC Israel
  • ENVB United States
  • Employees
  • SPRC N/A
  • ENVB N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • ENVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • ENVB Health Care
  • Exchange
  • SPRC Nasdaq
  • ENVB Nasdaq
  • Market Cap
  • SPRC 3.4M
  • ENVB 3.1M
  • IPO Year
  • SPRC N/A
  • ENVB N/A
  • Fundamental
  • Price
  • SPRC $7.95
  • ENVB $1.32
  • Analyst Decision
  • SPRC
  • ENVB Strong Buy
  • Analyst Count
  • SPRC 0
  • ENVB 1
  • Target Price
  • SPRC N/A
  • ENVB $10.00
  • AVG Volume (30 Days)
  • SPRC 29.6K
  • ENVB 154.2K
  • Earning Date
  • SPRC 02-15-2025
  • ENVB 08-11-2025
  • Dividend Yield
  • SPRC N/A
  • ENVB N/A
  • EPS Growth
  • SPRC N/A
  • ENVB N/A
  • EPS
  • SPRC N/A
  • ENVB N/A
  • Revenue
  • SPRC $1,306,000.00
  • ENVB N/A
  • Revenue This Year
  • SPRC N/A
  • ENVB N/A
  • Revenue Next Year
  • SPRC N/A
  • ENVB N/A
  • P/E Ratio
  • SPRC N/A
  • ENVB N/A
  • Revenue Growth
  • SPRC N/A
  • ENVB N/A
  • 52 Week Low
  • SPRC $4.14
  • ENVB $1.01
  • 52 Week High
  • SPRC $37.59
  • ENVB $11.55
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 58.06
  • ENVB 52.44
  • Support Level
  • SPRC $6.25
  • ENVB $1.18
  • Resistance Level
  • SPRC $8.50
  • ENVB $1.37
  • Average True Range (ATR)
  • SPRC 0.66
  • ENVB 0.06
  • MACD
  • SPRC 0.12
  • ENVB 0.01
  • Stochastic Oscillator
  • SPRC 58.54
  • ENVB 75.68

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: